Doctors are often failing to inform patients about the risk of birth defects to their potential unborn babies from a commonly used drug to treat epilepsy, according to a literature review by a University of Manchester researcher in the United Kingdom.
The study by PhD student Wejdan Shroukh also reveals that both clinical staff and patients can dangerously misjudge the risk of taking a group of drugs called teratogenic medicines, which are associated with birth defects.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!